WallStSmart
ARGX

argenx NV ADR

NASDAQ: ARGX · HEALTHCARE · BIOTECHNOLOGY

$776.02
+0.13% today

Updated 2026-04-29

Market cap
$48.76B
P/E ratio
39.81
P/S ratio
11.51x
EPS (TTM)
$19.60
Dividend yield
52W range
$510 – $935
Volume
0.3M

argenx NV ADR (ARGX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201020112012201320142015201620172018201920202021202220232024
Total assets$12.26M$31.94M$22.93M$34.54M$58.51M$50.25M$111.24M$444.98M$661.70M$1.61B$2.28B$2.85B$3.13B$4.54B$6.20B
Cash & equivalents
Current assets$11.89M$31.57M$22.48M$33.73M$69.77M$48.26M$107.06M$440.06M$654.82M$1.54B$2.06B$2.54B$2.77B$4.12B$4.88B
Total liabilities$2.03M$4.04M$6.28M$4.57M$10.25M$9.43M$44.59M$31.16M$45.83M$429.81M$605.36M$316.05M$320.56M$444.95M$704.24M
Current liabilities$2.03M$4.04M$6.28M$4.57M$10.25M$9.43M$34.00M$29.41M$45.82M$179.70M$328.49M$301.24M$302.28M$422.99M$669.92M
Long-term debt$0.00$0.00$0.00$0.00$0.00$0.00
Shareholder equity
Retained earnings$-8.41M$-12.52M$-25.60M$-35.20M$-43.54M$-55.89M$-76.24M$-120.65M$-194.01M$-383.48M$-991.93M$-1.40B$-2.11B$-2.40B$-1.57B
Accounts receivable$1.39M$986326.00$568677.00$1.52M$1.59M$719000.00$1.12M$845000.00$3.65M$36.17M$7.44M$38.22M$277.27M$499.27M$909.10M
Inventory$1.00$1.00$1.00$1.00$1.00$1.00$2.00$2.00$2.00$-1.02B$25.20M$109.08M$228.35M$310.55M$407.23M
Goodwill$0.00$0.00$0.00$0.00$0.00$0.00$6.30M